8legs: Vapor large-scale clinical trial

#1 out of 1

Breakthrough test puts scientists a breath away from beating pancreatic cancer

A breath-based test is being tested in a large UK trial to detect pancreatic cancer early.
The VAPOR study, run by Imperial College London with Pancreatic Cancer UK, spans 40 sites in the UK.
Researchers aim to enroll about 6,000 patients to assess breath VOCs linked to cancer.
The test detects volatile organic compounds in breath to signal cancer presence.
Pancreatic cancer often shows nonspecific early symptoms and is hard to diagnose early.
UK cases of pancreatic cancer exceed 10,000 annually with high mortality.
The study is funded by collaboration between Imperial College London and Pancreatic Cancer UK.
Experts expect the trial results to influence future early-detection strategies.
The UK trial location includes Scotland, Wales, and England.
Holistic aims focus on reducing late-stage diagnoses and improving survival prospects.

Vote 0